US · Healthcare

Assertio Therapeutics Inc (ASRT)

Drug Manufacturers - Specialty & Generic

Assertio Therapeutics Inc (ASRT) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ASRT

P/E ratio

18.00

Assertio Therapeutics Inc (ASRT) — FAQ

What is ASRT's P/E ratio?

The price-to-earnings (P/E) ratio for Assertio Therapeutics Inc (ASRT) is 18.00 (data as of 2026-05-23).

Does Assertio Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Assertio Therapeutics Inc (ASRT). Check the MyAverix Finance app for the latest dividend data.

What sector is Assertio Therapeutics Inc in?

Assertio Therapeutics Inc (ASRT) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ASRT listed on?

ASRT is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)